<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>23(1)</volume><submitter>Baek S</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Tyrosine kinase (TK) plays a crucial role in the pathogenesis of idiopathic pulmonary fibrosis. Here, we aimed to investigate whether radotinib (Rb) could inhibit pulmonary fibrosis by inhibiting TK in vitro and in vivo.&lt;h4>Methods&lt;/h4>The antifibrotic effects of Rb in transforming growth factor-β (TGF-β)1-stimulated A549 cells were determined using real-time polymerase chain reaction, western blotting, and immunocytochemistry assays. Rb inhibition of bleomycin-induced lung fibrosis in Sprague Dawley (SD) rats was determined by histopathological and​ immunohistochemical analyses. Rb-interfering metabolites were analyzed using LC-MS/MS.&lt;h4>Results&lt;/h4>Rb concentrations of up to 1000 nM did not affect the viability of A549 cells, but Rb (30 nM) significantly reduced expres</pubmed_abstract><journal>BMC pharmacology &amp; toxicology</journal><pagination>93</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9753032</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing.</pubmed_title><pmcid>PMC9753032</pmcid><pubmed_authors>Jeon JY</pubmed_authors><pubmed_authors>Yun HJ</pubmed_authors><pubmed_authors>Nam MH</pubmed_authors><pubmed_authors>Lee KP</pubmed_authors><pubmed_authors>Kwon SH</pubmed_authors><pubmed_authors>Ju HS</pubmed_authors><pubmed_authors>Lee GY</pubmed_authors><pubmed_authors>Cho DJ</pubmed_authors><pubmed_authors>Baek S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Radotinib attenuates TGFβ -mediated pulmonary fibrosis in vitro and in vivo: exploring the potential of drug repurposing.</name><description>&lt;h4>Background&lt;/h4>Tyrosine kinase (TK) plays a crucial role in the pathogenesis of idiopathic pulmonary fibrosis. Here, we aimed to investigate whether radotinib (Rb) could inhibit pulmonary fibrosis by inhibiting TK in vitro and in vivo.&lt;h4>Methods&lt;/h4>The antifibrotic effects of Rb in transforming growth factor-β (TGF-β)1-stimulated A549 cells were determined using real-time polymerase chain reaction, western blotting, and immunocytochemistry assays. Rb inhibition of bleomycin-induced lung fibrosis in Sprague Dawley (SD) rats was determined by histopathological and​ immunohistochemical analyses. Rb-interfering metabolites were analyzed using LC-MS/MS.&lt;h4>Results&lt;/h4>Rb concentrations of up to 1000 nM did not affect the viability of A549 cells, but Rb (30 nM) significantly reduced expres</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-04T13:46:13.264Z</modification><creation>2025-02-19T01:07:06.151Z</creation></dates><accession>S-EPMC9753032</accession><cross_references><pubmed>36522756</pubmed><doi>10.1186/s40360-022-00634-x</doi></cross_references></HashMap>